Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53326#.VL3BYyzQrzE
2Laboratory of Drug Analysis, Faculty of Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
3Laboratory Service, Institute of Research in Science of Health, Kinshasa, Democratic Republic of Congo.
4Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of Congo.
KEYWORDS
Cite this paper
[1] | Hay, S.I., Guerra, C.A., Tatem, A.J., Noor, A.M. and Snow, R.W. (2004) The Global Distribution and Population at Risk of Malaria: Past, Present and Future. The Lancet Infectious Diseases, 4, 327-336. http://dx.doi.org/10.1016/S1473-3099(04)01043-6 |
[2] | Ambroise, T. (2000) Traitement du paludisme: Prévenir les résistances par les associations d’antipaludiques. Médecine Tropicale, 60, 219-222. |
[3] | Geyer, G. (2001) Les combinaisons thérapeutiques antipaludiques: Rapport d’une consultation technique. Organisation Mondiale de la Santé (World Health Organization), Genève, Suisse, 5-24. |
[4] | Mutabingwa, T., Anthony, D., Heller, A., Hallett, R., Ahmed, J., Drakeley, C., Greenwood, B.M. and Whitty, C. (2005) Amodiaquine Alone, Amodiaquine + Sulfadoxinepyrimethamine, Amodiaquine + Artesunate, and Artemether-Lumefantrine for Outpatient Treatment of Malaria in Tanzanian Children: A Four-Arm Randomized Effectiveness Trial. The Lancet, 365, 1474-1480. http://dx.doi.org/10.1016/S0140-6736(05)66417-3 |
[5] | Tall, A., Rabarijaona, L., Robert, V., Bedja, S., Ariey, F. and Randrianarivelojosia, M. (2007) Efficacy of Artesunate plus Amodiaquine, Artesunate plus Sulfadoxine-Pyrimethamine and Chloroquine plus Sulfadoxine-Pyrimethamine in Patients with Uncomplicated Plasmodium Falciparum in the Comoros Union. Acta Tropica, 102, 176-181. http://dx.doi.org/10.1016/j.actatropica.2007.03.004 |
[6] | Van Vugt, M., Looareesuwan, S., Wilairatana, P., McGready, R., Villegas, L., Gathmann, I., Mull, R., Brockman, A., White, N.J. and Nosten, F. (2000) Artemether-Lumefantrine for the Treatment of Multidrug-Resistant Falciparum Malaria, Transactions of the Royal. Society of Tropical Medicine and Hygiene, 94, 545-548. http://dx.doi.org/10.1016/S0035-9203(00)90082-8 |
[7] | South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group (2005) Artesunate versus Quinine for Treatment of Severe Falciparum Malaria: A Randomised Trial. Lancet, 366, 717-725. http://dx.doi.org/10.1016/S0140-6736(05)67176-0 |
[8] | Panusa, A., Multari, G., Incarnato, G. and Gagliardi, L. (2007) High-Performance Liquid Chromatography Analysis of Anti-Inflammatory Pharmaceuticals with Ultraviolet and Electrospray-Mass Spectrometry Detection in Suspected Counterfeit Homeopathic Medicinal Products. Journal of Pharmaceutical and Biomedical Analysis, 43, 1221-1227. http://dx.doi.org/10.1016/j.jpba.2006.10.012 |
[9] | Newton, P.N., Lee Sue, J., Goodman, C., Fernández Facundo, M., Yeung, S., Phanouvong, S., Kaur, H., Amin, A.A., Whitty, C.J.M., Kokwaro, G.O., Lindegårdh, N., Lukulay, P., White, L.J., Day, N.P.J., Green, M.D. and White, N.J. (2009) Guidelines for Field Surveys of the Quality of Medicines: A Proposal. PloS Medicine, 6, 0252-0257. |
[10] | Mazière, M. (2007) Pharmaceutiques, Dossier Contrefaçon. PR Editions, Tour Ariane 5-7 place de la Pyramide 92080 La Défense, Cedex, France, 68-73. |
[11] | Newton, P.N., Dondorp, A., Green, M., Mayxay, M. and White, N.J. (2003) Counterfeit Artesunate Antimalarials in Southeast Asia. The Lancet, 362, 169. http://dx.doi.org/10.1016/S0140-6736(03)13872-X |
[12] | Caporal-Gauthier, J., Nivet, J.M., Algranti, P., Guilloteau, M., Histe, M., Lallier, M., N’guyen-Huu, J.J. and Russoto, R. (1992) Guide de validation analytique, Rapport d’une commission SFSTP, I Méthodologie. STP Pharma Pratiques, 2, 205-226. |
[13] | Notes explicative III/844/87-FR (1989) Commission des Communautés Européennes. Groupe de travail du Comité des spécialités pharmaceutiques, Bruxelles-Luxembourg, 8. |
[14] | Text on Validation of Analytical Procedures: Definitions and Terminology (Q2A) (2005) Tripartite International Conference on Harmonization (ICH) Text. ICH Technical Coordination, Londres. |
[15] | Text on Validation of Analytical Procedures: Methodology (Q2B) (2005) Tripartite International Conference on Harmonization (ICH) Text. ICH Technical Coordination, Londres. |
[16] | Vessman, J. (1996) Selectivity or Specificity? Validation of Analytical Methods from the Perspective of an Analytical Chemist in the Pharmaceutical Industry. Journal of Pharmaceutical and Biomedical Analysis, 14, 867-869. http://dx.doi.org/10.1016/0731-7085(95)01679-1 |
[17] | Food and Drug Administration (1995) International Conference on Harmonization: Guideline on Validation of Analytical Procedures: Definitions and Terminology. Federal Register, 60, 11260-11262. |
[18] | Food and Drug Administration (1997) International Conference on Harmonization: Guideline on Validation of Analytical Procedures: Methodology. Federal Register, 62, 27463-27467. |
[19] | Chapuzet, E., Mercier, N., Bervoas-Martin, S., Boulanger, B., Chevalier, P., Chiap, P., Granjean, D., Hubert, P., Lagorce, P., Lallier, M., Laparra, M.C., Laurentie, M. and Nivet, J.C. (1997) Méthodes chromatographiques de dosage dans les milieux biologiques: Stratégie de validation. STP Pharma Pratiques, 7, 169-194. |
[20] | Hubert, Ph., Chiap, P., Crommen, J., Boulanger, B., Chapuzet, E., Mercier, N., Bervoas-Martin, S., Chevalier, P., Grandjean, D., Lagorce, P., Lallier, M., Laparra, M.C., Laurentie, M. and Nivet, J.C. (1999) The SFSTP Guide on the Validation of Chromatographic Methods for Drug Bioanalysis: From the Washington Conference to the Laboratory. Analytica Chimica Acta, 391, 135-148. http://dx.doi.org/10.1016/S0003-2670(99)00106-3 |
[21] | Feinberg, M. and Raguènès, N. (1999) Development and Application of a Standardized Validation Procedure for Food Chemistry Laboratories. Analytica Chimica Acta, 391, 239-252. http://dx.doi.org/10.1016/S0003-2670(99)00120-8 |
[22] | Ermer, J. (2001) Validation in Pharmaceutical Analysis. Part I: An Integrated Approach. Journal of Pharmaceutical and Biomedical Analysis, 24, 755-767. http://dx.doi.org/10.1016/S0731-7085(00)00530-6 |
[23] | Hubert, P., Nguyen-Huu, J.J., Boulanger, B., Chapuzet, E., Chiap, P., Cohen, N., Compagnon, P.A., Dewé, W., Feinberg, M., Lallier, M., Laurentie, M., Mercier, N., Muzard, G., Nivet, C. and Valat, L. (2003) Validation des procédures analytiques quantitatives: Harmonisation des démarches. STP Pharma Pratiques, 13, 101-138. |
[24] | Boulanger, B., Chiap, P., Dewé, W., Crommen, J. and Hubert, Ph. (2003) An Analysis of the SFSTP Guide on Validation of Chromatographic Bioanalytical Methods: Progresses and Limitations. Journal of Pharmaceutical and Biomedical Analysis, 32, 753-765. http://dx.doi.org/10.1016/S0731-7085(03)00182-1 |
[25] | United States Pharmacopeial Convention (2009) USP Monographs, United States Pharmacopeial Convention 37, National Formulary 32, Rockville, MD, USA. |
[26] | Mee, R. (1988) Estimation of the Percentage of a Normal Distribution Lying Outside a Specified Interval. Communications in Statistics: Theory and Methods, 17, 1465-1479. |
[27] | Marini, R.D., Chiap, P., Boulanger, B., Rozet, E., Rudaz, S., Crommen, J. and Hubert, Ph. (2006) LC Method for the Determination of R-Timolol in S-Timolol Maleate: Validation of Its Ability to Quantify and Uncertainty Assessment. Talanta, 68, 1166-1175. http://dx.doi.org/10.1016/j.talanta.2005.07.026 eww150120lx |
\